198986
4-Methyl-2-oxopentanoic acid sodium salt hydrate
≥98%
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(CH3)2CHCH2COCO2Na · xH2O
CAS Number:
Molecular Weight:
152.12 (anhydrous basis)
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
Assay:
≥98%
Form:
solid
InChI
1S/C6H10O3.Na.H2O/c1-4(2)3-5(7)6(8)9;;/h4H,3H2,1-2H3,(H,8,9);;1H2/q;+1;/p-1
SMILES string
O.[Na+].CC(C)CC(=O)C([O-])=O
InChI key
FUDIEMDWYRETTC-UHFFFAOYSA-M
assay
≥98%
form
solid
mp
280 °C (dec.) (lit.)
Application
Condensation with α-amino ketones and subsequent cyclization provides pyrazinones.
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Heterocycles, 31, 1647-1647 (1990)
D A Roberts et al.
Journal of medicinal chemistry, 33(9), 2326-2334 (1990-09-01)
A series of 1,2,4-triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity, which incorporate (1S,2S)-2-amino-1,3-dicyclohexyl-1-hydroxypropane, statine (Sta), and (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy-pentanoic acid (ACHPA) transition-state mimetics, have been prepared. Structure-activity relationships for renin inhibitory activity in the series are consistent with the 2-[8-isobutyl-6-phenyl-1,2,4-triazolo[4,3-a]pyrazin-3-yl]-3-(3 pyridyl)propionic acid
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service